ARCHIVES

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Awards $1.2 Million To Mt. Sinai To Establish Specialized Cancer Center

July 26, 1974

Stop Cancer Foundation’s Future In Question, May Not Deliver All Of Funds Promised to NCI

January 18, 1991

New Criteria For Comprehensive center Status finalized

November 17, 1989

In Brief: Shubik, Rhoads, Dixon Affiliations With Industry Lister By House Subcommittee

June 11, 1976

Proteomics Promises Ways To Track Response To Therapy

April 25, 2003

NSABP Operations Office Moves Across Town To Allegheny

December 13, 1996